Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

Philippe Moreau*, Niels W.C.J. Van De Donk, Jesus San Miguel, Henk Lokhorst, Hareth Nahi, Dina Ben-Yehuda, Michele Cavo, Gordon Cook, Michel Delforge, Hermann Einsele, Sonja Zweegman, Heinz Ludwig, Christoph Driessen, Antonio Palumbo, Thierry Facon, Torben Plesner, Meletios Dimopoulos, Pia Sondergeld, Pieter Sonneveld, María Victoria Mateos

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Immunology and Microbiology